Company / Free Cash Flow per Share
Cue Biopharma, Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.35
FY2025
5-year range
-$1.31 / -$0.35
FY2021-FY2025
Trend
+54.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has increased for 4 consecutive years, from $-1.31 in FY2021 to $-0.35 in FY2025.
Based on SEC 10-K filings.
-0.35 in FY2025.
Improved from $-0.85 to $-0.35 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Cue Biopharma, Inc.'s free cash flow per share has grown for 4 consecutive years.
- In FY2025, free cash flow per share increased 54.1% year-over-year.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.35 | +54.1% |
| FY2024 | -$0.77 | +8.9% |
| FY2023 | -$0.85 | +35.1% |
| FY2022 | -$1.30 | +0.5% |
| FY2021 | -$1.31 | -12.8% |
| FY2020 | -$1.16 | +15.0% |
| FY2019 | -$1.37 | -101.8% |
| FY2018 | -$0.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026